CEP1347-VHL-02

N/A

Report date: 2024/09/20 14:48:06
NME

Base Information

Drug NameCEP1347-VHL-02
Drug Alias NameCEP1347-VHL-02
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 11 degraders
TargetsMitogen-activated protein kinase kinase kinase 11
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A